We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Pharmafair is an online marketplace for the pharmaceutical supply chain, from the wholesaler to the end consumer. The company estimates that the pharmaceutical market in the UK is worth £43 billion, and it aims to be a major contender in this segment. It plans to use stock exchange trading models to enhance the feel, liquidity and functionality of its application. Its app will also have the ability to list the sale or request purchase of a product and show live news feeds, watchlists, and price alerts in the pharma industry. The company is looking to raise between £75,000 and £100,000 for pre/post-launch marketing and working capital to improve its application further.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £273
The Fitfck application (parented by The Social Station Media Group) is a fitness dating app designed to connect like-minded fitness enthusiasts within a socially isolating lifestyle. The app is based on the founders' experience and has been described as 'The UK's fastest-growing fitness social app' by Google, London. The company witnessed 100,000 sign-ups in its first year at a cost per install of £0.30 (Industry average £1.20), has working relationships with Google, Facebook and YouTube, and is available to interested franchisees in 30+ countries. The application has 60,000+ followers across social media handles such as Instagram, Facebook, and Twitter. It has been featured in publications such as Daily Mail, Metro, and London Loves Business. It will use the investment to pay salaries to its staff, increase marketing initiatives, manage server costs, and other expenses. 

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Tom & Teddy Limited is a family-centric global swimwear brand started by Bristol-based female-founder. Tom & Teddy is a beachwear brand for men & boys that has sold more than 55,000 shorts in 2018 generating a revenue of approximately US$1.8m. The shorts are made in a quick-dry microfibre fabric with UV protection and a super-soft finish. The company aims to grow to £8m by the year 2023 (with significant upside potential), £1.6m EBIT.

Pitch Rated

75%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Alert Technology Limited is set to transform health and safety best practice for asbestos management by introducing ALERT - a new generation of real-time asbestos monitoring. With the large potential market, Alert will give market priority to the sectors who have demonstrated the greatest need. ALERT is the only solution to the global problem that impacts 30+ industry sectors. Till now, they have successfully launched the ALERT PRO 1000-the first model in the range and won an industry award in the asbestos category. With the investment, they will strengthen their team by recruiting a new Sales Director, Technical Sales Support, Technicians and Service Engineers to boost the in-house team, expand distribution, drive sales, scale-up assembly and service customers.

Pitch Rated

74%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £10,000
Patria Watch Co is a 127-year old luxury Swiss watch brand originally founded in Bienne, Switzerland in 1982. The brand has been revived by Patria Ltd as a UK company and is ready to take on the emerging market for wristwatches. Patria has already produced its first line of watches with its first edition coming out in April, 2020.  The brand has been featured in Forbes and has a partnership with luxury lifestyle publication 'WatchAnish.' The funds raised will be used in marketing and development of online magazines to showcase their range of luxury watches.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £7,207
GymBuddy is an online platform that enables consumers to find, book, and attend a gym location, services, or products offered and operated by fitness studios, gyms, trainers, venues, or other third parties. Users can easily, through filtered searches on the app, view descriptions, and contact information of specialists within the fitness industry such as personal trainers, nutritionists, and physiotherapists. The UK fitness industry alone is currently worth over £5 billion. Based on recent statistics, the average gym membership in the UK costs members £40 a month, which often ties them into lengthy contracts. The GymBuddy app will enter the Health & Fitness club sector as a multi-gym membership feature that gives users access to gyms and various fitness plans, without the need for bricks-and-mortar locations under its brand. The company is seeking an investment of £400,000 to expand its brand identity and bring more users to its ecosystem to generate profits.

Pitch Rated

30%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph